Conference
Extended overall survival results from the POLO study of active maintenance olaparib in patients with metastatic pancreatic cancer and a germline BRCA mutation
Authors
Hammel P; Golan T; Reni M; Van Cutsem E; Macarulla Mercade T; Hall M; Park JO; Hochhauser D; Arnold D; Oh D-Y
Volume
33
Pagination
pp. S1137-S1137
Publisher
ELSEVIER
Publication Date
September 1, 2022
Name of conference
Annual Meeting of the European-Society-for-Medical-Oncology (ESMO)
Conference place
ELECTR NETWORK
Conference start date
September 9, 2022
Conference end date
September 13, 2022
Conference proceedings
ANNALS OF ONCOLOGY
Issue
7
ISSN
0923-7534
